{"title":"Incidence and Predictors of Remission of Childhood Uveitis in a Large Community Cohort","authors":"Ying Qian , Richie Houhong Xu , Juleon W. Rabbani , Lue-Yen Tucker","doi":"10.1016/j.ajo.2025.05.024","DOIUrl":null,"url":null,"abstract":"<div><h3>PURPOSE</h3><div>To describe a large community cohort of incident cases of childhood uveitis and to determine incidence and predictors of remission.</div></div><div><h3>DESIGN</h3><div>Retrospective clinical cohort study.</div></div><div><h3>METHODS</h3><div>Participants were patients aged 16 years or younger who were newly diagnosed with uveitis at Kaiser Permanente Northern California, a large integrated health care system, between January 1, 2010, and December 31, 2020. Data were extracted electronically from medical records, pharmacy records, and health plan database. Incidence and predictors were determined using Cox regression modeling and survival analysis. The main outcome measure was the incidence of drug-free remission. For the primary analysis, remission was defined as no recurrence of active uveitis for at least 3 months beyond cessation of drug effect. Factors potentially predictive of remission were assessed.</div></div><div><h3>RESULTS</h3><div>Of 1643 patients with incident uveitis, 277 incident cases of noninfectious uveitis were identified, including 145 patients (52.3%) with chronic noninfectious uveitis who were treated for at least 3 months; of these, 75 patients (51.7%) were female and 102 patients (70.3%) had anterior uveitis. Mean age at initial treatment was 9.8 (SD = 4.31) years. Mean follow-up time was 41.3 (SD = 31.8) months. At 5-year follow-up, the cumulative probability of drug-free remission was 50.8% (95% CI = 41.7%-60.6%). Age at start of treatment (adjusted hazard ratio [aHR] = 1.18. 95% CI = 1.1-1.28) and male sex (aHR = 1.85; 95% CI = 1.11-3.08) were associated with higher incidence of remission. Baseline characteristics that did not reach significance included bilateral disease, anterior uveitis, posterior synechiae, cataract, juvenile idiopathic arthritis, visual acuity, tobacco exposure, and socioeconomic status. A dose–response survival effect was seen with increasing age at presentation.</div></div><div><h3>CONCLUSIONS</h3><div>Almost half of the children with newly diagnosed chronic noninfectious uveitis achieved drug-free remission within 5 years of follow-up, with the youngest least likely to achieve remission and the oldest most likely to achieve remission. Female sex and younger age at presentation were independent predictors of lack of remission of childhood uveitis.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"277 ","pages":"Pages 221-229"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002939425002648","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
PURPOSE
To describe a large community cohort of incident cases of childhood uveitis and to determine incidence and predictors of remission.
DESIGN
Retrospective clinical cohort study.
METHODS
Participants were patients aged 16 years or younger who were newly diagnosed with uveitis at Kaiser Permanente Northern California, a large integrated health care system, between January 1, 2010, and December 31, 2020. Data were extracted electronically from medical records, pharmacy records, and health plan database. Incidence and predictors were determined using Cox regression modeling and survival analysis. The main outcome measure was the incidence of drug-free remission. For the primary analysis, remission was defined as no recurrence of active uveitis for at least 3 months beyond cessation of drug effect. Factors potentially predictive of remission were assessed.
RESULTS
Of 1643 patients with incident uveitis, 277 incident cases of noninfectious uveitis were identified, including 145 patients (52.3%) with chronic noninfectious uveitis who were treated for at least 3 months; of these, 75 patients (51.7%) were female and 102 patients (70.3%) had anterior uveitis. Mean age at initial treatment was 9.8 (SD = 4.31) years. Mean follow-up time was 41.3 (SD = 31.8) months. At 5-year follow-up, the cumulative probability of drug-free remission was 50.8% (95% CI = 41.7%-60.6%). Age at start of treatment (adjusted hazard ratio [aHR] = 1.18. 95% CI = 1.1-1.28) and male sex (aHR = 1.85; 95% CI = 1.11-3.08) were associated with higher incidence of remission. Baseline characteristics that did not reach significance included bilateral disease, anterior uveitis, posterior synechiae, cataract, juvenile idiopathic arthritis, visual acuity, tobacco exposure, and socioeconomic status. A dose–response survival effect was seen with increasing age at presentation.
CONCLUSIONS
Almost half of the children with newly diagnosed chronic noninfectious uveitis achieved drug-free remission within 5 years of follow-up, with the youngest least likely to achieve remission and the oldest most likely to achieve remission. Female sex and younger age at presentation were independent predictors of lack of remission of childhood uveitis.
期刊介绍:
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.
The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.
Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.